David J. Llewellyn

University of Exeter — United Kingdom

Medicine · Health Sciences

67h-index15.2kcitations314works4.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Dementia and Cognitive Impairment Research(78), Vitamin D Research Studies(33), Health disparities and outcomes(28), Nutritional Studies and Diet(27), Ion-surface interactions and analysis(19)

Publications312 total

Cloud computing for equitable, data-driven dementia medicine
The Lancet Digital Health·2025· 2 citedOpen Access
The relationship between anaemia, haemoglobin levels, and cognitive function: Evidence in two population-based cohorts from India and the United States
Neurobiology of Disease·2025Open Access
Machine learning applications in vascular neuroimaging for the diagnosis and prognosis of cognitive impairment and dementia: a systematic review and meta-analysis
Alzheimer s Research & Therapy·2025· 1 citedOpen Access
Uncovering the multivariate genetic architecture of frailty with genomic structural equation modeling
Nature Genetics·2025· 6 citedOpen Access
Hormone replacement therapy and dementia risk among postmenopausal women: evidence from the UK Biobank
2025Open Access
Social determinants of dementia: A scoping review
Alzheimer s & Dementia·2025· 4 citedOpen Access
Impact of Vitamin D Supplementation on Cognition in Adults With Mild to Moderate Vitamin D Deficiency: Outcomes From the VitaMIND Randomized Controlled Trial
Journal of the American Medical Directors Association·2025· 4 citedOpen Access
Early Behavioral Markers of Loss of Financial Capacity
JAMA Network Open·2025Open Access
Hemoglobin in the brain frontal lobe tissue of patients with Alzheimer’s disease is susceptible to reactive nitrogen species-mediated oxidative damage
Redox Biology·2025· 4 citedOpen Access
Low-dose tolvaptan for the treatment of SIADH-induced hyponatraemia: a meta-analysis and systematic review of the efficacy and safety
Endocrine Abstracts·2025
Data‐driven discovery of associations between prescribed drugs and dementia risk: A systematic review
Alzheimer s & Dementia Translational Research & Clinical Interventions·2025· 9 citedOpen Access
From research to clinical practice: Consensus guidelines for Neuroimaging AI tools for the Memory clinic (Neuro-AIM)
SSRN Electronic Journal·2025Open Access
Machine learning applications in vascular neuroimaging for the diagnosis and prognosis of cognitive impairment and dementia: a systematic review and meta-analysis
2024Open Access
Impact of Vitamin D supplementation on cognition in adults with mild to moderate vitamin D deficiency: Outcomes from the VitaMIND randomised controlled trial
2024· 1 citedOpen Access
Frailty Trajectories Preceding Dementia in the US and UK
JAMA Neurology·2024· 31 citedOpen Access
Aortic reservoir-excess pressure parameters are associated with worse cognitive function in people with untreated stage II/III hypertension
Journal of Hypertension·2024
Harnessing transcriptomic signals for amyotrophic lateral sclerosis to identify novel drugs and enhance risk prediction
Heliyon·2024· 12 citedOpen Access
Uncovering the multivariate genetic architecture of frailty with genomic structural equation modelling
2024· 2 citedOpen Access
Detection of cognitive deficits years prior to clinical diagnosis across neurological conditions
2024Open Access
Medication and supplement pharmacokinetic changes following bariatric surgery: A systematic review and meta‐analysis
Obesity Reviews·2024· 9 citedOpen Access
page 1 of 16Next →

Frequent Co-authors

Kenneth M. Langa(16), Iain Lang(14), Janice M. Ranson(8), Carol Brayne(7), David Melzer(6), Ilianna Lourida(5), Fiona E. Matthews(5), Thomas J. Littlejohns(4), Maya Soni(4), Cédric Annweiler(4), Guy G. Potter(4), Brenda L. Plassman(4), Cornelia M. van Duijn(4), Elżbieta Kuźma(3), Ruth E. Hubbard(3), Kenneth Rockwood(3), Isobel E.M. Evans(3), Bob Woods(3), Linda Clare(3), David C. Steffens(3)